Oncology News

Diabetes and high blood glucose levels in individuals without a diabetes diagnosis correlated with increased risks for liver cancer and major chronic liver diseases, according to a large prospective study of Chinese adults.

Radiation segmentectomy conferred comparable response rates, tumor control and survival outcomes as curative-intent treatments among certain patients with early-stage hepatocellular carcinoma, according to findings published in Radiology.

Compliance with hepatocellular carcinoma surveillance correlated with early diagnosis, better allocation of curative treatment and longer overall survival among patients with hepatitis C- or hepatitis B-associated compensated cirrhosis, according to a recently published study.

Stivarga therapy provided clinical benefit to patients with hepatocellular carcinoma and had similar adverse event rates regardless of the last Nexavar dose or time-to-progression on prior Nexavar therapy, according to a recently published study.

Metastatic cancer cells originating from colorectal cancer can reprogram their metabolism to create an enzyme that feeds on fructose in the liver, which increases proliferation, according to a recently published study.

Alcohol consumption correlated with significant changes to the oral microbiome that have been previously linked to alcohol-related diseases like periodontal disease, GI cancers, head and neck cancers and heart disease, according to new research published in the journal Microbiome.

PARIS — Alcohol abstinence did not reduce the risk for hepatocellular carcinoma among patients with Child-Pugh class A or B alcohol-related cirrhosis, according to a presentation at the International Liver Congress 2018.

PARIS — Treating hepatitis C virus in the early stage of disease saves money in drug and medical costs while lowering risk for decompensated cirrhosis, hepatocellular carcinoma, liver transplant and liver-related death, according to a presentation at the International Liver Congress 2018.

PARIS — Beginning Wednesday, April 11, Healio Gastroenterology and Liver Disease will provide live coverage from the International Liver Congress 2018.

Patients with hepatitis C have an increased risk for disease progression to cirrhosis and potentially hepatocellular carcinoma. Recent studies have focused on defining liver cancer risks related to HCV progression and the rates of liver cancer after HCV clearance with new direct-acting antivirals.